The lawsuit resulted from an investigation, which began in 1996, that alleged that Knoll Pharmaceuticals and parent company BASF were violating consumer protection laws by attempting to prevent publication of the results of a research study showing that generic and competitive brand name levothyroxine drugs were equivalent to the Synthroid brand.In other words, back in the 1990s, the makers of Synthroid essentially did conspire to keep people from buying more affordable generic equivalents of the drug. It was not about "keeping people sick." It was about keeping people who need synthetic thyroid hormone from spending their money on products made by someone other than Knoll.
You are not logged in, either login or create an account to post comments
One of the side effects of overactive thyroid (or too high doses of synthroid) can be weight loss, and lowering the dose could result in weight gain. Could this be one of her concerns?
posted by xingcat at 9:52 PM on September 17, 2012 [3 favorites]